EX-FILING FEES 4 d468441dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

CALCULATION OF FILING FEE TABLES

Post-Effective Amendment to Form S-3

(Form Type)

PMV Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

      Security
Type		    Security
Class
Title		    Fee  
Calculation  
or Carry  
Forward  
Rule  		   

Amount
Registered

    Proposed  
Maximum  
Offering  
Price per  
Unit  		   

Maximum
Aggregate
Offering

Price

    Fee Rate    Amount of  
Registration  
Fee  		    Carry  
Forward  
Form  
Type  		    Carry  
Forward  
File No  		    Carry  
Forward  
Initial  
Effective  
Date   		   Filing Fee
Previously
Paid in
Connection
with
Unsold
Securities
to be
Carried
Forward
Newly Registered Securities
Fees to Be Paid    Equity    Common Stock, par value $0.00001 per share    457(r)    (1)(2)    (3)    (3)         —                    
     Equity    Preferred Stock, par value $0.00001 per share    457(r)    (1)(2)    (3)    (3)         —                    
     Debt    Debt Securities    457(r)    (1)(2)    (3)    (3)         —                    
     Equity    Warrants    457(r)    (1)(2)    (3)    (3)         —                    
     Other    Subscription Rights    457(r)    (1)(2)    (3)    (3)         —                    
     Other    Purchase Contracts    457(r)    (1)(2)    (3)    (3)         —                    
     Equity    Units(5)    457(r)    (1)(2)    (3)    (3)         —                    
     Unallocated (Universal) Shelf    (1)    457(o)    (1)(2)    (3)    $200,000,000(3)      $110.20  
per  
$1,000,000  		    $22,040                    
Carry Forward Securities
Carry
Forward
Securities		    Equity    Common Stock, par value $0.00001 per share    415(a)(6)    —      N/A    $150,000,000           $13,905(4)    S-3ASR    333-260012    October 4,
2021		    $13,905
Total Offering Amounts           $350,000,000           $35,945                    
Total Fee Previously Paid           —         $13,905(4)                    
Total Fee Offsets           —         —                    
Net Fee Due      (3)    (3)           $22,040                    

Table 2: Fee Offset Claims and Sources

 

     Registrant or
Filer Name		    Form
or
Filing
Type		   File
Number		    Initial
Filing
Date		    Filing
Date		    Fee
Offset
Claimed		    Security
Type
Associated
with Fee
Offset
Claimed		    Security
Title
Associated
with
Fee
Offset
Claimed		    Unsold
Securities
Associated
with Fee
Offset
Claimed		    Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed		      Fee
Paid
with Fee
Offset
Source		  
Rules 457(b) and 0-11(a)(2)

 

Fee Offset Claims                                                             
Fee Offset Sources                                                             
Rule 457(p)

 

Fee Offset Claims                                                             
Fee Offset Sources   PMV Pharmaceuticals, Inc.    S-3ASR   333-260012    October 4, 2021    October 4, 2021    $13,905    Equity    Common Stock, par value $0.00001 per share    N/A      $150,000,000        $13,905  
(1)

The securities registered consists of up to $200,000,000 of an indeterminate number of (a) shares of common stock, (b) shares of preferred stock, (c) debt securities, (d) warrants to purchase common stock, preferred stock or debt securities of the registrant, (e) subscription rights to purchase common stock, preferred stock, debt securities, warrants or units consisting of some or all of these securities of the registrant, (f) purchase contracts, and (g) units consisting of some or all of these securities, as may be sold from time to time by the registrant. There are also being registered hereunder an indeterminate number of shares of common stock and preferred stock as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance.

(2)

Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any share splits, share dividends or similar transactions.

(3)

The proposed maximum per security and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.E. of Form S-3 under the Securities Act. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities, or that are issued in units. In no event will the aggregate offering price of all securities sold by the registrant from time to time pursuant to this registration statement exceed $200,000,000.

(4)

The registrant previously paid a fee of $13,905 related to $150,000,000 of the registrant’s common stock that could have been issued and sold under a certain sales agreement with Jefferies LLC pursuant to a prospectus supplement filed by the registrant on October 4, 2021. Of such shares, $150,000,000 were unsold, and the registration fee in the amount of $13,905 related thereto is applied to the registrant’s total registration fee pursuant to Rule 415(a)(6). Accordingly, the registrant is paying the registration fee due less the $13,905 that was previously paid.

(5)

Consisting of some or all of the securities listed above, in any combination, including common stock, preferred stock, debt securities, warrants, purchase contracts and subscription rights.